Literature DB >> 4306213

Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.

M Tsukamura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4306213     DOI: 10.1164/arrd.1969.99.5.780

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  5 in total

1.  Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.

Authors:  Courtney E Maus; Bonnie B Plikaytis; Thomas M Shinnick
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Direct observation therapy with appropriate treatment regimens was associated with a decline in second-line drug-resistant tuberculosis in Taiwan.

Authors:  J-Y Chien; C-C Tsou; S-T Chien; C-J Yu; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-12       Impact factor: 3.267

3.  Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.

Authors:  Amber Arnold; Graham S Cooke; Onn Min Kon; Martin Dedicoat; Marc Lipman; Angela Loyse; Irina Chis Ster; Thomas S Harrison
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

4.  Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.

Authors:  Rashid Akbergenov; Dmitri Shcherbakov; Tanja Matt; Stefan Duscha; Martin Meyer; Daniel N Wilson; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

5.  Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.

Authors:  Courtney E Maus; Bonnie B Plikaytis; Thomas M Shinnick
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.